[Alagille's syndrome: a family case and its association with hepatocellular carcinoma]

E Pérez Becerra1, M Fuster, M Fraga

  • 1Departamento de Anatomía Patológica, Facultad de Medicina, Hospital Clínico Universitario, Santiago de Compostela.

Insights

This report details two Alagille syndrome cases in a father and son. The father developed hepatocarcinoma, highlighting a rare association with Alagille syndrome and emphasizing long-term survival despite the condition.

Area of Science:

  • Hepatology
  • Genetics
  • Pediatrics

Background:

  • Alagille syndrome is a genetic disorder affecting the liver, heart, and other organs.
  • It is characterized by a reduced number of bile ducts in the liver, leading to cholestasis.
  • Hepatocarcinoma is a rare but serious complication associated with Alagille syndrome.

Observation:

  • A 6-year-old boy presented with neonatal cholestasis, pruritus, and characteristic Alagille syndrome phenotype.
  • Liver biopsy confirmed the absence of intrahepatic bile ducts.
  • The boy's father, diagnosed with Alagille syndrome, died at 43 from hepatocarcinoma, with his liver biopsy also showing absent intrahepatic bile ducts.

Findings:

  • This case highlights the father-son transmission of Alagille syndrome.
  • It documents a rare association between Alagille syndrome and hepatocarcinoma, previously reported in six cases.
  • The father's long survival and reproductive success despite Alagille syndrome and hepatocarcinoma are noteworthy.

Implications:

  • This case underscores the importance of long-term monitoring for complications like hepatocarcinoma in Alagille syndrome patients.
  • It contributes to understanding the genetic and clinical spectrum of Alagille syndrome.
  • Further research may elucidate the mechanisms linking Alagille syndrome to hepatocarcinogenesis and long-term survival factors.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...